Key result
Younger age with established CVD is linked to ~35% lower preventive medication dispensing vs older adults.
Why the study?
Blood pressure-lowering and lipid-lowering medications reduce cardiovascular risk, but international data suggest pharmacotherapy use increases with age, indicating potential under-utilisation in younger patients with known CVD.
Observational (n=7,622)
Yes
Effect estimate: 30-40% less likely
No takes yet. Share an insight, caveat, or question.
Underuse of BPL/LL therapy greatest in younger CVD patients; leaves open whether age-targeted interventions improve uptake in primary care.
Mehta et al. (2011) conducted an observational in Cardiovascular disease (n=7,622). Younger age (35-54 years) vs. Older age (65-75 years) was evaluated on Dispensing of blood pressure-lowering (BPL) and/or lipid-lowering (LL) medications (30-40% less likely). Younger patients (aged 35-44) with known cardiovascular disease were 30-40% less likely to be dispensed preventive medications compared to those aged 65-75.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: